Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
Name | Price | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anti-FCRL2 antibody (130-210 aa) (STJ192453) | Login | Anti-FCRL2 antibody (130-210 aa) (STJ192453) | ||||||||||||||||
|
||||||||||||||||||
Anti-PTP4A3 antibody (40-120 aa) (STJ192454) | Login | Anti-PTP4A3 antibody (40-120 aa) (STJ192454) | ||||||||||||||||
|
||||||||||||||||||
Anti-SLAMF8 antibody (110-190 aa) (STJ192455) | Login | Anti-SLAMF8 antibody (110-190 aa) (STJ192455) | ||||||||||||||||
|
||||||||||||||||||
Anti-S100A8 antibody (30-110 aa) (STJ192456) | Login | Anti-S100A8 antibody (30-110 aa) (STJ192456) | ||||||||||||||||
|
||||||||||||||||||
Anti-STUB1 antibody (160-240 aa) (STJ192459) | Login | Anti-STUB1 antibody (160-240 aa) (STJ192459) | ||||||||||||||||
|
||||||||||||||||||
Anti-EGFL7 antibody (140-220 aa) (STJ192463) | Login | Anti-EGFL7 antibody (140-220 aa) (STJ192463) | ||||||||||||||||
|
||||||||||||||||||
Anti-TLR9 antibody (400-480 aa) (STJ192464) | Login | Anti-TLR9 antibody (400-480 aa) (STJ192464) | ||||||||||||||||
|
||||||||||||||||||
Anti-DLL3 antibody (510-590 aa) (STJ192465) | Login | Anti-DLL3 antibody (510-590 aa) (STJ192465) | ||||||||||||||||
|
||||||||||||||||||
Anti-PRLR antibody (80-160 aa) (STJ192473) | Login | Anti-PRLR antibody (80-160 aa) (STJ192473) | ||||||||||||||||
|
||||||||||||||||||
Anti-HBZ antibody (10-90 aa) (STJ192474) | Login | Anti-HBZ antibody (10-90 aa) (STJ192474) | ||||||||||||||||
|
||||||||||||||||||
Anti-CRNN antibody (380-460 aa) (STJ192475) | Login | Anti-CRNN antibody (380-460 aa) (STJ192475) | ||||||||||||||||
|
||||||||||||||||||
Anti-AMIGO2 antibody (270-350 aa) (STJ192476) | Login | Anti-AMIGO2 antibody (270-350 aa) (STJ192476) | ||||||||||||||||
|
||||||||||||||||||
Anti-C1QTNF4 antibody (40-120 aa) (STJ192485) | Login | Anti-C1QTNF4 antibody (40-120 aa) (STJ192485) | ||||||||||||||||
|
||||||||||||||||||
Anti-B2M antibody (40-120 aa) (STJ192491) | Login | Anti-B2M antibody (40-120 aa) (STJ192491) | ||||||||||||||||
|
||||||||||||||||||
Anti-TIPARP antibody (450-530 aa) (STJ192499) | Login | Anti-TIPARP antibody (450-530 aa) (STJ192499) | ||||||||||||||||
|
||||||||||||||||||
Anti-INSRR antibody (80-160 aa) (STJ192379) | Login | Anti-INSRR antibody (80-160 aa) (STJ192379) | ||||||||||||||||
|
||||||||||||||||||
Anti-PRSS2 antibody (40-120 aa) (STJ192380) | Login | Anti-PRSS2 antibody (40-120 aa) (STJ192380) | ||||||||||||||||
|
||||||||||||||||||
Anti-LMO2 antibody (1-80 aa) (STJ192385) | Login | Anti-LMO2 antibody (1-80 aa) (STJ192385) | ||||||||||||||||
|
||||||||||||||||||
Anti-PARP9 antibody (450-530 aa) (STJ192432) | Login | Anti-PARP9 antibody (450-530 aa) (STJ192432) | ||||||||||||||||
|
||||||||||||||||||
Anti-SORT1 antibody (260-340 aa) (STJ192435) | Login | Anti-SORT1 antibody (260-340 aa) (STJ192435) | ||||||||||||||||
|
||||||||||||||||||
Anti-HES1 antibody (STJ192322) | Login | Anti-HES1 antibody (STJ192322) | ||||||||||||||||
|
||||||||||||||||||
Anti-FLRT2 antibody (170-250 aa) (STJ192439) | Login | Anti-FLRT2 antibody (170-250 aa) (STJ192439) | ||||||||||||||||
|
||||||||||||||||||
Anti-BEX3 antibody (1-80 aa) (STJ192330) | Login | Anti-BEX3 antibody (1-80 aa) (STJ192330) | ||||||||||||||||
|
||||||||||||||||||
Anti-C5 antibody (690-770 aa) (STJ192331) | Login | Anti-C5 antibody (690-770 aa) (STJ192331) | ||||||||||||||||
|
||||||||||||||||||
Anti-MICA antibody (30-110 aa) (STJ192332) | Login | Anti-MICA antibody (30-110 aa) (STJ192332) | ||||||||||||||||
|